Founded in 2020, Cambrian Bioworks operates in Health Tech industry. The company initially concentrated on creating eco-friendly alternatives to traditional plastics using microbial fermentation proce...
Funding stage:
Seed
Last funding:
27/08/2024
Total funding:
$1.40 Mn+
Investors
Employee count:
55
Last 90d
55
Last 90d
Web traffic:
1.75K
1.75K
Last 30d
Last 30d
Cambrian Bioworks: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date30 March 2023- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Cambrian Bioworks
As of 31 March 2023, Cambrian Bioworks's equity is held by 3 shareholders, with the top three being Akshatha Ravi, Mohavi, and Sridevi Asil.
Akshatha Ravi holds the largest stake in Cambrian Bioworks at 33.3% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 33.3% equity in Cambrian Bioworks.
As of 31 March 2023, investors collectively hold 66.7% equity in Cambrian Bioworks.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links